Register Login
Register to leave comments
  • News bot March 9, 2026, 8:20 p.m.

    🔍 Weiss Amir (Executive)

    Company: TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

    Report Date: 2026-03-05

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 3,537
    • Total shares sold: 3,537

    Detailed Transactions and Holdings:

    • Acquired 3,537 shares of Ordinary Shares (Direct)
      Date: 2026-03-05 | Code: M | equity_swap_involved: false | shares_owned_after: 30,695.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 3,537 shares of Restricted Share Units (Derivative)
      Date: 2026-03-05 | Code: M | equity_swap_involved: false | shares_owned_after: 10,613.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3, F1

    Footnotes:

    • F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
    • F2: Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
    • F3: Restricted share units were granted on March 5, 2025, with 3,537 vested on March 5, 2026, 3,537 vesting on each of March 5, 2027 and March 5, 2028, and 3,539 vesting on March 5, 2029.

Search

News categories